Insider · SEC Form 4 · Director
Rhodes Jason P
In the 12 months to Nov 8, 2026, on the open market: sold $99.4M of DYN. Filed a median of 2 business days after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $0Insider sales below: $99.4M
- DYNSold: Dyne Therapeutics, Inc. $54.0M
- DYNSold: Dyne Therapeutics, Inc. $11.2M
- DYNSold: Dyne Therapeutics, Inc. $6.9M
- DYNSold: Dyne Therapeutics, Inc. $10.9M
- DYNSold: Dyne Therapeutics, Inc. $4.1M
- DYNSold: Dyne Therapeutics, Inc. $6.6M
- DYNSold: Dyne Therapeutics, Inc. $509K
- DYNSold: Dyne Therapeutics, Inc. $2.0M
- DYNSold: Dyne Therapeutics, Inc. $3.1M
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.